For individuals exploring options for weight management, GLP-1 receptor agonists like semaglutide have emerged as significant advancements
Diabetologia 54 , S38 (2011)
3quart for 12week protocol
Pancreatitis (inflammation of the pancreas): Symptoms may include severe upper abdominal pain that doesnt go away, vomiting, and nausea Gallbladder disease (gallstones or gallbladder inflammation): Symptoms may include sudden and intense abdominal pain, nausea, vomiting, fever and chills Kidney problems: Changes in urination (either going more or less frequently), along with swelling in feet and ankles Hypersensitivity or allergic reactions (including anaphylaxis ): Shortness of breath, itching and swelling near the injection site, dizziness Diabetic retinopathy: People with type 2 diabetes and a history of diabetic retinopathy (a complication that affects the blood vessels in the eye) may experience worsening symptoms, including blurred vision, spots, and floaters : Symptoms include fast heartbeat, shakiness, dizziness, and confusion
At maximum doses over 48 weeks, Retatrutide achieved 24.2% average weight loss compared to Mazdutides 14%
your diabetes team can advise whether you are eligible [9] Practical steps to reduce your risk include: Informing your healthcare team of all medications you are taking, including over-the-counter products and supplements Not skipping meals, even if your appetite is significantly reduced small, regular meals can help maintain stable glucose levels Carrying fast-acting glucose with you at all times Wearing a medical alert bracelet or carrying identification indicating your diabetes status and medications Avoiding excessive alcohol, which can impair the liver's ability to release glucose and mask hypoglycaemia symptoms [5] [6] Discussing any planned changes to diet or exercise with your care team before making them Driving safety is an important consideration if you are at risk of hypoglycaemia
